Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.

× No keyword cloud information.

10 in total

Review 1. MPTP mouse models of Parkinson's disease: an update.

Authors: Gloria E Meredith; David J Rademacher
Journal: J Parkinsons Dis Date: 2011 Impact factor: 5.568

2. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors: R E Ryan; S A Ross; J Drago; R E Loiacono
Journal: Br J Pharmacol Date: 2001-04 Impact factor: 8.739

3. A microdialysis study of the effects of the nicotinic agonist RJR-2403 on cortical release of acetylcholine and biogenic amines.

Authors: K L Summers; P Lippiello; E Giacobini
Journal: Neurochem Res Date: 1996-10 Impact factor: 3.996

Review 4. Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanisms.

Authors: G Mudo; N Belluardo; K Fuxe
Journal: J Neural Transm (Vienna) Date: 2006-08-17 Impact factor: 3.575

5. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes.

Authors: J M Kulak; T A Nguyen; B M Olivera; J M McIntosh
Journal: J Neurosci Date: 1997-07-15 Impact factor: 6.167

6. Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.

Authors: A M Janson; K Fuxe; M Goldstein
Journal: Clin Investig Date: 1992 Mar-Apr

Review 7. Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery.

Authors: Henry A Lester; Cheng Xiao; Rahul Srinivasan; Cagdas D Son; Julie Miwa; Rigo Pantoja; Matthew R Banghart; Dennis A Dougherty; Alison M Goate; Jen C Wang
Journal: AAPS J Date: 2009-03-12 Impact factor: 4.009

Review 8. Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors: Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal: CNS Drugs Date: 2003 Impact factor: 5.749

9. Studies on the interactions of tobacco leaf and tobacco smoke constituents and monoamine oxidase.

Authors: Kay Castagnoli; Stefanus J Steyn; Geraldine Magnin; Cornelis J Van Der Schyf; Izel Fourie; Ashraf Khalil; Neal Castagnoli
Journal: Neurotox Res Date: 2002-03 Impact factor: 3.911

10. Neuroprotective and anti-inflammatory effects of a therapy combining agonists of nicotinic α7 and σ1 receptors in a rat model of Parkinson's disease.

Authors: Steven Vetel; Laura Foucault-Fruchard; Claire Tronel; Frédéric Buron; Jackie Vergote; Sylvie Bodard; Sylvain Routier; Sophie Sérrière; Sylvie Chalon
Journal: Neural Regen Res Date: 2021-06 Impact factor: 5.135

10 in total